Ozempic

New Jersey Courts Brace for Centralization of Ozempic and Wegovy NAION Lawsuits Amid Growing Concerns

by

Newark, New Jersey — A significant legal action is underway as plaintiffs seek to centralize lawsuits related to the diabetes medication Ozempic and the weight-loss drug Wegovy in New Jersey state court. This move comes amid growing concerns over the medications’ potential links to a rare eye condition known as non-arteritic anterior ischemic optic neuropathy (NAION). The request for consolidation aims to streamline the legal proceedings, potentially allowing the cases to be handled more efficiently in a single jurisdiction. Legal representatives argue that unifying these complaints could save time and resources for both the courts … Read more

US Court Confirms FDA’s Decision to Ban Compounded Versions of Ozempic and Wegovy

by

A federal judge in New York has supported a U.S. Food and Drug Administration decision that prohibits the compounding of alternatives to the diabetes medication Ozempic and its weight-loss counterpart, Wegovy. The ruling comes amid soaring demand for these drugs, which have gained popularity for their effectiveness in managing weight. The case arose when a group of pharmacies sought to produce compounded versions of these medications, which are manufactured by Novo Nordisk. These compounded alternatives would allow pharmacists to create custom formulations for patients, yet the FDA argued that such practices may pose risks of … Read more

Navigate the Legal Storm: Talc Specialist Takes Center Stage as New Claims Link Ozempic to Vision Loss

by

In Los Angeles, California, a prominent attorney known for his expertise in talc litigation is once again in the media spotlight as new lawsuits emerge. These lawsuits allege that the diabetes medication Ozempic may lead to serious ocular side effects, including potential blindness, raising concerns about the drug’s safety profile. Amanda Bronstad, reporting on the evolving legal landscape, emphasizes the growing scrutiny surrounding pharmaceuticals and their unexpected consequences. The new claims present a formidable challenge for drug manufacturers as regulatory scrutiny intensifies and public health implications surface. Recent legal actions assert that patients using Ozempic … Read more

“Litigation Landscape Update: Major Multidistrict Cases Surge as New Developments Emerge in AFFF, Talcum Powder, and Ozempic Lawsuits”

by

Chicago, Illinois — As May approaches, significant developments are unfolding in various high-profile multidistrict litigations (MDLs) in the United States, with the spotlight turning to ongoing legal battles involving products like Roundup, Depo-Provera, and hair relaxers. The MDL concerning aqueous film-forming foam (AFFF) has seen a notable increase, with over 400 new lawsuits filed last month, propelling it to become the fifth-largest MDL in the nation. Progress remains steady as the litigation follows established bellwether tracks. Depo-Provera, a birth control injectable, has also gained traction recently, as the number of active lawsuits more than doubled, … Read more